Sino-Agri Leading Biosciences Co.,Ltd (SHA:603970)

SHA:603970 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	379.9	405.31	864.09	1,932	966.97	1,005
Trading Asset Securities	500	1,000	792.2	1,000	506.93	503.57
Cash & Short-Term Investments	879.9	1,405	1,656	2,932	1,474	1,508
Cash Growth	-21.71%	-15.15%	-43.50%	98.91%	-2.28%	125.02%
Accounts Receivable	2,418	1,692	1,708	320.93	199.29	623.6
Other Receivables	47.38	49.42	59.03	116.35	37.94	49.61
Receivables	2,465	1,741	1,767	437.29	237.23	673.21
Inventory	2,662	1,573	1,536	1,563	1,716	1,236
Other Current Assets	880.51	633.58	779.25	1,047	1,077	414.8
Total Current Assets	6,888	5,353	5,738	5,979	4,504	3,833
Property, Plant & Equipment	59.11	58.53	71.84	60.39	73.77	42.06
Long-Term Investments	95.44	95.09	99.13	113.2	86.17	5.84
Other Intangible Assets	3.54	3.65	4.29	5.14	50.53	119.38
Long-Term Deferred Tax Assets	47.2	43.95	50.38	44.72	25.3	21.78
Long-Term Deferred Charges	4.96	5.67	2.53	1.48	1.69	2.34
Other Long-Term Assets	42	42	42	42	-	-
Total Assets	7,140	5,602	6,008	6,246	4,742	4,024
Accounts Payable	3,207	2,118	2,759	2,648	1,298	964.1
Accrued Expenses	57.79	83.75	81.12	75.32	40.48	59.99
Short-Term Debt	718.52	628.48	628.87	800.73	942	1,117
Current Portion of Long-Term Debt	-	-	100.08	0.09	-	7.5
Current Portion of Leases	5.97	8.73	10.05	3.5	9.71	-
Current Income Taxes Payable	65.66	25.19	30.86	55.09	24.68	20.67
Current Unearned Revenue	1,219	897.8	624.42	932.11	893.39	543.53
Other Current Liabilities	101.38	139.55	152.86	116.85	221.24	147.11
Total Current Liabilities	5,375	3,901	4,388	4,632	3,429	2,860
Long-Term Debt	-	-	-	100	-	-
Long-Term Leases	8.28	4.32	9.29	5.61	5.46	-
Long-Term Unearned Revenue	0.72	0.15	0.33	-	8.39	9.87
Long-Term Deferred Tax Liabilities	10.45	9.74	12.58	18.18	12.11	4.81
Other Long-Term Liabilities	4.28	4.28	4.28	6.01	5.59	5.82
Total Liabilities	5,399	3,920	4,414	4,762	3,461	2,881
Common Stock	268.8	268.8	268.8	192	192	192
Additional Paid-In Capital	238.23	238.23	238.23	302.15	298.02	298.02
Retained Earnings	1,047	992.72	910.31	791.07	648.12	535.41
Comprehensive Income & Other	20.47	20.69	22.2	32.93	33	-0.16
Total Common Equity	1,574	1,520	1,440	1,318	1,171	1,025
Minority Interest	167.22	162.24	154.62	166.2	109.75	118.17
Shareholders' Equity	1,741	1,683	1,594	1,484	1,281	1,143
Total Liabilities & Equity	7,140	5,602	6,008	6,246	4,742	4,024
Total Debt	732.78	641.53	748.28	909.93	957.18	1,125
Net Cash (Debt)	147.12	763.78	908.02	2,022	516.72	383.58
Net Cash Growth	84.72%	-15.88%	-55.09%	291.28%	34.71%	-
Net Cash Per Share	0.55	2.84	3.38	7.52	1.92	1.43
Filing Date Shares Outstanding	268.8	268.8	268.8	268.8	268.8	268.8
Total Common Shares Outstanding	268.8	268.8	268.8	268.8	268.8	268.8
Working Capital	1,513	1,452	1,350	1,347	1,075	972.54
Book Value Per Share	5.86	5.66	5.36	4.90	4.36	3.81
Tangible Book Value	1,571	1,517	1,435	1,313	1,121	905.89
Tangible Book Value Per Share	5.84	5.64	5.34	4.88	4.17	3.37
Buildings	-	28.31	17.54	17.54	17.54	33.32
Machinery	-	87.7	89.14	95.86	98.37	68.72
Construction In Progress	-	-	9.32	-	-	4.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.